Access to COVID-19 Therapeutics in Long-Term Care Facilities- Public-Private Collaboration

This study presents a pioneering approach aimed at facilitating timely access to monoclonal antibodies for LTC facilities through a unique partnership between a state health department and a private mobile healthcare provider. The primary goal was to provide swift therapeutic intervention without imposing additional burdens on LTC facilities.